Long-term secondary prevention of acute myocardial infarction (SEPAT) – guidelines adherence and outcome
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2261
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Long-term secondary prevention of acute myocardial infarction (SEPAT) – guidelines adherence and outcome ; volume:16 ; number:1 ; day:17 ; month:11 ; year:2016 ; pages:1-8 ; date:12.2016
BMC cardiovascular disorders ; 16, Heft 1 (17.11.2016), 1-8, 12.2016
- Urheber
-
Ergatoudes, Constantinos
- Beteiligte Personen und Organisationen
-
Thunström, Erik
Rosengren, Annika
Björck, Lena
Bengtsson Boström, Kristina
Falk, Kristin
Fu, Michael
SpringerLink (Online service)
- DOI
-
10.1186/s12872-016-0400-6
- URN
-
urn:nbn:de:1111-201612089284
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ergatoudes, Constantinos
- Thunström, Erik
- Rosengren, Annika
- Björck, Lena
- Bengtsson Boström, Kristina
- Falk, Kristin
- Fu, Michael
- SpringerLink (Online service)
Ähnliche Objekte (12)
Periprocedural Myocardial Infarction
Reconsidering treatment guidelines for acute myocardial infarction during the COVID-19 pandemic
Going beyond the mean: economic benefits of myocardial infarction secondary prevention
Effects of adherence to pharmacological secondary prevention after acute myocardial infarction on health care costs – an analysis of real-world data
Type II Myocardial Infarction
Pregnancy-related myocardial infarction
An unusual myocardial infarction
Smoking cessation and participation in secondary prevention programs after acute myocardial infarction
Photoresponsive Hydrogel‐Coated Upconversion Cyanobacteria Nanocapsules for Myocardial Infarction Prevention and Treatment
Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction
Right Ventricular Infarction in Inferior Wall Myocardial Infarction
Prescribing and medical non-adherence after myocardial infarction: qualitative interviews with general practitioners in Germany
Periprocedural Myocardial Infarction
Reconsidering treatment guidelines for acute myocardial infarction during the COVID-19 pandemic
Going beyond the mean: economic benefits of myocardial infarction secondary prevention
Effects of adherence to pharmacological secondary prevention after acute myocardial infarction on health care costs – an analysis of real-world data
Type II Myocardial Infarction
Pregnancy-related myocardial infarction
An unusual myocardial infarction
Smoking cessation and participation in secondary prevention programs after acute myocardial infarction
Photoresponsive Hydrogel‐Coated Upconversion Cyanobacteria Nanocapsules for Myocardial Infarction Prevention and Treatment
Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction
Right Ventricular Infarction in Inferior Wall Myocardial Infarction
Prescribing and medical non-adherence after myocardial infarction: qualitative interviews with general practitioners in Germany
Periprocedural Myocardial Infarction
Reconsidering treatment guidelines for acute myocardial infarction during the COVID-19 pandemic
Going beyond the mean: economic benefits of myocardial infarction secondary prevention
Effects of adherence to pharmacological secondary prevention after acute myocardial infarction on health care costs – an analysis of real-world data
Type II Myocardial Infarction
Pregnancy-related myocardial infarction
An unusual myocardial infarction
Smoking cessation and participation in secondary prevention programs after acute myocardial infarction
Photoresponsive Hydrogel‐Coated Upconversion Cyanobacteria Nanocapsules for Myocardial Infarction Prevention and Treatment
Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction
Right Ventricular Infarction in Inferior Wall Myocardial Infarction